Orbit Pharma Laboratories Llp Profile
Key Indicators
- Obligation of Contribution ₹ 1.00 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.71 Cr
- Satisfied Charges ₹ 1.75 M
About Orbit Pharma Laboratories Llp
Orbit Pharma Laboratories Llp (OPLL) is 4 Year, 4 Months old Limited Liability Partnership 26 October 2020. Its registered office is in Gandhi Nagar, Gujarat, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 1.00 M as per MCA.
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAU-4237
- Incorporation Date
26 Oct 2020
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Ahmedabad
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Orbit Pharma Laboratories Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naranbhai Kikani  | Designated Partner | 26-Oct-2020 | Current |
| Kunal Kikani | Designated Partner | 01-Sep-2022 | Current |
Financial Performance of Orbit Pharma Laboratories Llp.
Enhance accessibility to Orbit Pharma Laboratories Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Orbit Pharma Laboratories Llp?
Unlock access to Orbit Pharma Laboratories Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Orbit Pharma Laboratories LimitedNaranbhai Kikani and Kunal Kikani are mutual person
- Khwaish Organics Llp
Kunal Kikani is a mutual person
Charges (Loans)
₹117.10 M
₹1.75 M
Charges Breakdown by Lending Institutions
- Bank Of Maharashtra : 11.71 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2022 | Bank Of Maharashtra | ₹2.11 Cr | Open |
| 26 Oct 2020 | Bank Of Maharashtra | ₹6.00 M | Open |
| 26 Oct 2020 | Bank Of Maharashtra | ₹4.50 Cr | Open |
| 26 Oct 2020 | Bank Of Maharashtra | ₹3.00 Cr | Open |
| 26 Oct 2020 | Bank Of Maharashtra | ₹1.50 Cr | Open |
How Many Employees Work at Orbit Pharma Laboratories Llp?
Orbit Pharma Laboratories Llp has a workforce of 35 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orbit Pharma Laboratories Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orbit Pharma Laboratories Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
